Skip to content

Clinical trials

Leukemia, Myelomonocytic, Chronic trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Phase: Not applicable Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20043
20051
20062
20081
20092
20103
20132
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated6
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center5
M.D. Anderson Cancer Center2
OHSU Knight Cancer Institute2
University of California, San Francisco2
Wake Forest University Health Sciences2
Barbara Ann Karmanos Cancer Institute1
City of Hope Medical Center1
Jonsson Comprehensive Cancer Center1
Martin, Paul1
Masonic Cancer Center, University of Minnesota1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic24
Congenital Abnormalities20
Leukemia, Lymphocytic, Chronic, B-Cell20
Lymphoma, Large B-Cell, Diffuse20
Multiple Myeloma20
Myeloproliferative Disorders20
Precursor Cell Lymphoblastic Leukemia-Lymphoma20
Burkitt Lymphoma19
Hodgkin Disease19
Leukemia, Myeloid, Acute19

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.